Slingshot members are tracking this corporate initiative:
Endo (ENDP) to Acquire BioSpecifics (BSTC) to Enhance Profitability of XIAFLEX and Qwo
Do you think this event is important to the companies below? How will it affect their stock price?
"Acquiring BioSpecifics is consistent with our strategic priority to expand and enhance our portfolio through additional investment in the significant long-term growth potential of both XIAFLEX and QWO - two of our most durable and differentiated products," said Blaise Coleman, President and Chief Executive Officer of Endo. "This transaction will also immediately enhance Endo's adjusted EBITDA and create significant value for shareholders of both organizations."
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: Oct 19, 2020 Projected Implementation: Q4, 2020 Relevance Tracked Until: Q1, 2021
Don’t see a project related to the strategic initiative you care about?
Related Keywords Xiaflex, Qwo